Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06TTT
|
|||
| Former ID |
DIB005927
|
|||
| Drug Name |
Recombinant Tat protein vaccine
|
|||
| Synonyms |
Recombinant Tat protein vaccine (HIV infection); RTat vaccine (human immunodeficiency virus infection),Istituto Superiore di Sanita; Recombinant Tat protein vaccine (HIV infection), Istituto Superiore di Sanita
Click to Show/Hide
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Phase 1 | [1] | |
| Company |
Istituto Superiore di Sanita
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00529698) Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.